Purpose The interaction between physical and mental health is complex. In this paper we
aim to provide an overview of the main components of this relationship and to identify how …

Background Patients with schizophrenia are at high risk of developing metabolic
abnormalities. Method A prospective study focusing on metabolic disturbances in patients …

Objective: To summarize the accumulated data on metabolic syndrome prevalence in
patients with schizophrenia, examine evidence for a biological contribution of the mental …

Diabetes mellitus occurs in schizophrenia patients at higher rates than in the general
population. Reasons for this elevated risk are poorly understood and have not been …

Background: The introduction of second-generation antipsychotics (SGAs) over the past 2
decades generated considerable optimism that better anti-psychotic treatments for …

OBJECTIVE: To evaluate the efficacy of non-pharmacological interventions for antipsychotic-
associated weight gain. METHODS: Systematic literature search and meta-analysis of …

Importance Long-acting injectable antipsychotics are used to reduce medication
nonadherence and relapse in schizophrenia-spectrum disorders. The relative effectiveness …

Newer antipsychotics introduced in clinical practice in recent years include clozapine,
risperidone, olanzapine, quetiapine, sertindole, ziprasidone, aripiprazole and amisulpride …

BackgroundMetabolic and cardiovascular health problems have become a major focus for
clinical care and research in schizophrenia. AimsTo evaluate the content and quality of …

Mental disorders are the greatest overall cause of disability. 1 Antipsychotic drugs (APDs)
are the most widely prescribed medications and are used frequently to control various …